Evolva Holding SA (ELVAF)

USD 0.9

(0.0%)

Market Cap (In USD)

6.49 Million

Revenue (In USD)

9.43 Million

Net Income (In USD)

-105.22 Million

Avg. Volume

33.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.822-1.1
PE
-
EPS
-
Beta Value
0.136
ISIN
CH1262055788
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Gerhard Lobmaier
Employee Count
-
Website
https://www.evolva.com
Ipo Date
2021-01-08
Details
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.